biotech
biotech Articles
GenMark Diagnostics shares shot up early on Wednesday after the company provided an update on its quarterly numbers and where it stands with its coronavirus test.
Published:
Co-Diagnostics shares popped on Monday after the company announced a key update from the FDA on its COVID-19 test kit.
Published:
Immunomedics shares soared on Monday after the announcements that a late-stage breast cancer study was halted early and a new chief executive officer was named.
Published:
In a recent report from Wedbush Securities, the boutique brokerage firm recaps the COVID-19 impact on its coverage universe. Here, 24/7 Wall St. has picked out some of Wedbush’s top picks within...
Published:
ElectroCore shares absolutely exploded on Friday after the company announced an update for its COVID-19 treatment.
Published:
Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
Published:
InflaRx shares jumped early on Wednesday after the company announced that it has enrolled its first patient into a clinical trial for the treatment of severe COVID-19-induced pneumonia.
Published:
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
Published:
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
Published:
Trinity Biotech released its fiscal fourth-quarter financial results on Tuesday morning, but that wasn’t what propelled the stock afterward.
Published:
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Published:
U.S. consumer confidence continues to decline, but the slide has slowed. On Sunday, the FDA and the Department of Health and Human Services okayed two drugs for use in the fight against COVID-19.
Published:
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting...
Published:
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published: